Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-032438

Chief Financial Officer sold 20,000 shares at an average $32.08 ($641,642)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-11 Exercise or conversion : show line 1 in the form +10,000 $6.55 $65,500 31,604 D
2021-05-11 Sale : show line 2 in the form −2,969 $30.81 $91,475 28,635 D
2021-05-11 Sale : show line 3 in the form −7,031 $31.84 $223,867 21,604 D
2021-05-12 Exercise or conversion : show line 4 in the form +10,000 $6.55 $65,500 31,604 D
2021-05-12 Sale : show line 5 in the form −10,000 $32.63 $326,300 21,604 D
Open-market sales · 20,000 sh · avg $32.08 · $641,642

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-11 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −10,000 140,000 D
2021-05-12 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −10,000 130,000 D
Loading xslF345X03/doc4.xml…